LivaNova - Public Comps and Valuation Multiples

LivaNova Overview

About LivaNova

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Founded

2015

HQ

Employees

2.9K+

Website

livanova.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $1.3B

LTM EBITDA $277M

EV

$2.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

LivaNova Financials

LivaNova has a last 12-month revenue of $1.3B and a last 12-month EBITDA of $277M.

In the most recent fiscal year, LivaNova achieved revenue of $1.3B and an EBITDA of $203M.

LivaNova expects next 12-month revenue of XXX and NTM EBITDA of XXX

See LivaNova valuation multiples based on analyst estimates

LivaNova P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$1.2B	$1.3B	XXX	XXX	XXX
Gross Profit	$707M	$771M	XXX	XXX	XXX
Gross Margin	61%	62%	XXX	XXX	XXX
EBITDA	$38.5M	$203M	XXX	XXX	XXX
EBITDA Margin	3%	16%	XXX	XXX	XXX
Net Profit	-$86.2M	$17.5M	XXX	XXX	XXX
Net Margin	-7%	1%	XXX	XXX	XXX
Net Debt	$327M	$320M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

LivaNova Stock Performance

As of April 15, 2025, LivaNova's stock price is $35.

LivaNova has current market cap of $1.9B, and EV of $2.2B.

See LivaNova trading valuation data

LivaNova Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.2B	$1.9B	XXX	XXX	XXX	XXX	$3.44

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

LivaNova Valuation Multiples

As of April 15, 2025, LivaNova has market cap of $1.9B and EV of $2.2B.

LivaNova's trades at 1.7x LTM EV/Revenue multiple, and 7.9x LTM EBITDA.

Analysts estimate LivaNova's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for LivaNova and 10K+ public comps

LivaNova Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$2.2B	XXX	XXX	XXX
EV/Revenue	1.7x	XXX	XXX	XXX
EV/EBITDA	10.7x	XXX	XXX	XXX
P/E	30.5x	XXX	XXX	XXX
P/E/Growth	0.4x	XXX	XXX	XXX
EV/FCF	16.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get LivaNova Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

LivaNova Valuation Multiples

LivaNova's NTM/LTM revenue growth is 4%

LivaNova's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, LivaNova's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate LivaNova's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for LivaNova and other 10K+ public comps

LivaNova Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	9%	XXX	XXX	XXX	XXX
EBITDA Margin	16%	XXX	XXX	XXX	XXX
EBITDA Growth	426%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	21%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.4M	XXX	XXX	XXX	XXX
Opex per Employee	$0.3M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	15%	XXX	XXX	XXX	XXX
Opex to Revenue	59%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry